240 related articles for article (PubMed ID: 15528193)
1. An Inhibitor of the F1 subunit of ATP synthase (IF1) modulates the activity of angiostatin on the endothelial cell surface.
Burwick NR; Wahl ML; Fang J; Zhong Z; Moser TL; Li B; Capaldi RA; Kenan DJ; Pizzo SV
J Biol Chem; 2005 Jan; 280(3):1740-5. PubMed ID: 15528193
[TBL] [Abstract][Full Text] [Related]
2. Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin.
Moser TL; Kenan DJ; Ashley TA; Roy JA; Goodman MD; Misra UK; Cheek DJ; Pizzo SV
Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6656-61. PubMed ID: 11381144
[TBL] [Abstract][Full Text] [Related]
3. Angiostatin is directly cytotoxic to tumor cells at low extracellular pH: a mechanism dependent on cell surface-associated ATP synthase.
Chi SL; Pizzo SV
Cancer Res; 2006 Jan; 66(2):875-82. PubMed ID: 16424020
[TBL] [Abstract][Full Text] [Related]
4. Angiostatin binds ATP synthase on the surface of human endothelial cells.
Moser TL; Stack MS; Asplin I; Enghild JJ; Højrup P; Everitt L; Hubchak S; Schnaper HW; Pizzo SV
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2811-6. PubMed ID: 10077593
[TBL] [Abstract][Full Text] [Related]
5. Identification of functional domains and critical residues in the adenosinetriphosphatase inhibitor protein of mitochondrial F0F1 ATP synthase.
Papa S; Zanotti F; Cocco T; Perrucci C; Candita C; Minuto M
Eur J Biochem; 1996 Sep; 240(2):461-7. PubMed ID: 8841413
[TBL] [Abstract][Full Text] [Related]
6. Angiostatin-like activity of a monoclonal antibody to the catalytic subunit of F1F0 ATP synthase.
Chi SL; Wahl ML; Mowery YM; Shan S; Mukhopadhyay S; Hilderbrand SC; Kenan DJ; Lipes BD; Johnson CE; Marusich MF; Capaldi RA; Dewhirst MW; Pizzo SV
Cancer Res; 2007 May; 67(10):4716-24. PubMed ID: 17510399
[TBL] [Abstract][Full Text] [Related]
7. Ectopic localization of mitochondrial ATP synthase: a target for anti-angiogenesis intervention?
Kenan DJ; Wahl ML
J Bioenerg Biomembr; 2005 Dec; 37(6):461-5. PubMed ID: 16691484
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism on forcible ejection of ATPase inhibitory factor 1 from mitochondrial ATP synthase.
Kobayashi R; Ueno H; Okazaki KI; Noji H
Nat Commun; 2023 Mar; 14(1):1682. PubMed ID: 37002198
[TBL] [Abstract][Full Text] [Related]
9. Insight into the bind-lock mechanism of the yeast mitochondrial ATP synthase inhibitory peptide.
Corvest V; Sigalat C; Haraux F
Biochemistry; 2007 Jul; 46(29):8680-8. PubMed ID: 17595113
[TBL] [Abstract][Full Text] [Related]
10. Direct targeting of tumor cell F(1)F(0) ATP-synthase by radioiodine angiostatin in vitro and in vivo.
Jung KH; Song SH; Paik JY; Koh BH; Choe YS; Lee EJ; Kim BT; Lee KH
Cancer Biother Radiopharm; 2007 Oct; 22(5):704-12. PubMed ID: 17979573
[TBL] [Abstract][Full Text] [Related]
11. Modification of the mitochondrial F1-ATPase epsilon subunit, enhancement of the ATPase activity of the IF1-F1 complex and IF1-binding dependence of the conformation of the epsilon subunit.
Solaini G; Baracca A; Gabellieri E; Lenaz G
Biochem J; 1997 Oct; 327 ( Pt 2)(Pt 2):443-8. PubMed ID: 9359414
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of the release of the mitochondrial inhibitor protein. Correlation with synthesis and hydrolysis of ATP.
Lippe G; Sorgato MC; Harris DA
Biochim Biophys Acta; 1988 Mar; 933(1):1-11. PubMed ID: 2894852
[TBL] [Abstract][Full Text] [Related]
13. The compound BTB06584 is an IF1 -dependent selective inhibitor of the mitochondrial F1 Fo-ATPase.
Ivanes F; Faccenda D; Gatliff J; Ahmed AA; Cocco S; Cheng CH; Allan E; Russell C; Duchen MR; Campanella M
Br J Pharmacol; 2014 Sep; 171(18):4193-206. PubMed ID: 24641180
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the role and mechanism of IF1 and STF1 proteins, twin inhibitory peptides which interact with the yeast mitochondrial ATP synthase.
Venard R; Brèthes D; Giraud MF; Vaillier J; Velours J; Haraux F
Biochemistry; 2003 Jun; 42(24):7626-36. PubMed ID: 12809520
[TBL] [Abstract][Full Text] [Related]
15. Pigment epithelium-derived factor binds to cell-surface F(1)-ATP synthase.
Notari L; Arakaki N; Mueller D; Meier S; Amaral J; Becerra SP
FEBS J; 2010 May; 277(9):2192-205. PubMed ID: 20412062
[TBL] [Abstract][Full Text] [Related]
16. The inhibitor protein IF
Carroll J; Watt IN; Wright CJ; Ding S; Fearnley IM; Walker JE
J Biol Chem; 2024 Mar; 300(3):105690. PubMed ID: 38280428
[TBL] [Abstract][Full Text] [Related]
17. Pathway of binding of the intrinsically disordered mitochondrial inhibitor protein to F1-ATPase.
Bason JV; Montgomery MG; Leslie AG; Walker JE
Proc Natl Acad Sci U S A; 2014 Aug; 111(31):11305-10. PubMed ID: 25049402
[TBL] [Abstract][Full Text] [Related]
18. Effects of microenvironmental extracellular pH and extracellular matrix proteins on angiostatin's activity and on intracellular pH.
Wahl ML; Grant DS
Gen Pharmacol; 2000 Nov; 35(5):277-85. PubMed ID: 11888684
[TBL] [Abstract][Full Text] [Related]
19. Dimerization of F0F1ATP synthase from bovine heart is independent from the binding of the inhibitor protein IF1.
Tomasetig L; Di Pancrazio F; Harris DA; Mavelli I; Lippe G
Biochim Biophys Acta; 2002 Dec; 1556(2-3):133-41. PubMed ID: 12460670
[TBL] [Abstract][Full Text] [Related]
20. Angiostatin: a negative regulator of endothelial-dependent vasodilation.
Koshida R; Ou J; Matsunaga T; Chilian WM; Oldham KT; Ackerman AW; Pritchard KA
Circulation; 2003 Feb; 107(6):803-6. PubMed ID: 12591747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
